Photo: Doug Mills/The New York Times/Pool/Getty Images

Trump administration advisers are hinting at a willingness to spend billions and elevate their risk tolerance in the hope of getting coronavirus treatments out this year.

What they're saying: "There had been frustration about how slow CDC was moving on a vaccine, and there had been discussions on how to bypass some of the bureaucracy and speed the process up significantly," a White House official told Axios' Alayna Treene.

The plan: The administration wants to organize public-private partnerships — with taxpayers assuming the risk — to produce vaccines on scale before widespread trials have ended. 

  • "Called 'Operation Warp Speed,' the program will pull together private pharmaceutical companies, government agencies and the military to try to cut the development time for a vaccine by as much as eight months," Bloomberg reports.
  • Reality check: This is billed as a way to get 100 million doses to the public by the end of this year and shorten the 12- to 18-month timeline laid out by the NIH's Anthony Fauci, but even that window was extremely optimistic.

The higher risk tolerance: The administration is reportedly preparing to give an emergency use authorization for Gilead's remdesivir, despite mixed results in early trials, the N.Y. Times reports.

  • Remdesivir appears to help people recover modestly quicker, which could be encouraging for those who get sick, but this drug is not any kind of a "cure" for this novel coronavirus, Axios' Bob Herman reports. Faster means 11 days vs. 15.
  • The data, which is still undergoing peer review and wasn't expected until May, shows an "important proof of concept" for remdesivir, but it isn't necessarily a "knockout," the NIH's Anthony Fauci said at the White House today.
  • Flashback: President Trump was promoting chloroquine and hydroxychloroquine as recently as two weeks ago.

The bottom line: There's a lot of pressure to get treatments and eventually a vaccine out to the public faster — but don't get your hopes up.

Go deeper

Surgeon general urges flu shots to prevent "double whammy" with coronavirus

Surgeon General Jerome Adams the American Red Cross National Headquarters on July 30. Photo: Jim Watson/AFP via Getty Images

U.S. Surgeon General Jerome Adams on Friday stressed the importance of Americans getting flu vaccines for the next influenza season, noting that the country has "been backsliding in terms of vaccine confidence over the last several years."

Why it matters: A bad flu season could put even more strain on the country's health system resources, which are especially limited in domestic coronavirus epicenters like Florida and California.

Updated 8 hours ago - Health

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

The United Kingdom slumped into recession on Wednesday, as its gross domestic product GDP shrank 20.4% compared with the first three months of the year.

By the numbers: Over 741,400 people have died of the novel coronavirus globally and more than 20.2 million have tested positive, per Johns Hopkins. Almost 12.6 million have recovered from the virus.

Updated 26 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of noon ET: 20,391,697 — Total deaths: 744,211— Total recoveries: 12,625,076Map.
  2. U.S.: Total confirmed cases as of 11:30 a.m. ET: 5,161,612 — Total deaths: 164,690 — Total recoveries: 1,714,960 — Total tests: 63,252,257Map.
  3. Business: U.S. already feeling effects of ending unemployment benefits — U.S. producer prices rose last month by the most since October 2018.
  4. Public health: America is flying blind on its coronavirus response.
  5. Education: Gallup: America's confidence in public school system jumps to highest level since 2004.
  6. World: Lebanon reports coronavirus record, UN warns Beirut blast may drive cases higher